(no title)
jonahhorowitz | 7 months ago
- *For many large pharmaceutical companies ("Big Pharma"), marketing costs often exceed R&D spending.* In analyses of the top 10 drugmakers by revenue in 2020, 7 companies spent more on sales and marketing than on research and development. For example, Johnson & Johnson spent $22 billion on marketing compared to $12 billion on R&D; Bayer spent $18 billion on marketing vs. $8 billion on R&D[1][2].
- The combined marketing spend for these top 10 companies exceeded R&D by $36 billion (about 37%) in 2020[1][2].
[1] https://www.ahip.org/news/articles/new-study-in-the-midst-of... [2] https://www.csrxp.org/icymi-new-study-finds-big-pharma-spent...
markdown|7 months ago
Surely that's something that would be easier to get bipartisan support for, somewhat avoiding the "socialism vs capitalism" chasm between the parties that prevents meaningful healthcare reform.
mullingitover|7 months ago
[2] https://nadler.house.gov/news/documentsingle.aspx?DocumentID...